Green Thumb Industries (GTBIF) Other Non-Current Liabilities (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Other Non-Current Liabilities came in at $33.2 million in Q4 2023, up 16525.0% YoY from N/an in Q4 2022, and up 6.32% on a QoQ basis from $31.3 million in Q1 2023.
Green Thumb Industries (GTBIF) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 5 years of Other Non-Current Liabilities data on file, last reported at $33.2 million in Q4 2023.
- Quarterly Other Non-Current Liabilities rose 16525.0% year-over-year to $33.2 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $33.2 million (up 16525.0% YoY) and the FY2023 annual result came in at $33.2 million, up 16525.0% from the prior year.
- Other Non-Current Liabilities climbed to $33.2 million in Q4 2023, from $31.3 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $98.5 million in Q4 2021 to a low of $200000.0 in Q3 2022.
- A 5-year average of $30.1 million and a median of $24.1 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities plunged 99.8% — and 2023, when it surged 16525.0%.
- Tracing GTBIF's Other Non-Current Liabilities over 5 years: stood at $57.0 million in 2019, then sank by 83.83% to $9.2 million in 2020, then soared by 968.87% to $98.5 million in 2021, then sank by 99.8% to $200000.0 in 2022, then surged by 16525.0% to $33.2 million in 2023.
- The last three Other Non-Current Liabilities figures came in at $33.2 million (Q4 2023), $31.3 million (Q1 2023), and $200000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Green Thumb Industries | 1.69 Bn | 1.41 Bn | 137.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 203.45 Mn |
| Dec 31, 2025 | 203.45 Mn |
| Dec 31, 2023 | 33.25 Mn |
| Mar 31, 2023 | 31.27 Mn |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 16.95 Mn |
| Dec 31, 2021 | 98.50 Mn |
| Sep 30, 2021 | 61.85 Mn |
| Jun 30, 2021 | 47.46 Mn |
| Mar 31, 2021 | 45.30 Mn |
| Sep 30, 2020 | 9.22 Mn |
| Jun 30, 2020 | 8.99 Mn |
| Mar 31, 2020 | 8.50 Mn |
| Dec 31, 2019 | 56.99 Mn |